Kelly Patrick F. 4
4 · Forma Therapeutics Holdings, Inc. · Filed Apr 14, 2022
Insider Transaction Report
Form 4
Kelly Patrick F.
SVP, Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-04-08$5.05/sh+15,000$75,750→ 104,884 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-13−15,000→ 55,134 totalExercise: $5.05Exp: 2029-11-20→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]A total of 70,134 shares subject to an employee stock option were granted on November 21, 2019. 25% of the shares subject to this stock option vested on November 21, 2020, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.